NGI+ – The Next Generation of APSD Testing

Enhanced Durability.
Greater Compatibility.
Reliable APSD Data.

For experts conducting Aerodynamic Particle Size Distribution (APSD) measurements, the NGI+ takes inhalation drug testing to the next level. Built upon the trusted Next Generation Impactor (NGI) design, the NGI+ features enhanced corrosion resistance, improved chemical compatibility, and extended equipment life - ensuring more reliable, repeatable APSD results across a wider range of formulations.
 

NGI+ Advantages for APSD Testing

• Precise APSD Characterization – Maintains industry-leading impactor performance while supporting a broader range of drugs and delivery systems.
• Enhanced Corrosion & Chemical Resistance – Ideal for nebulizers, biologics, and high-saline formulations, ensuring long-term impactor integrity.
• More Robust Cleaning Options – Supports harsher cleaning agents and automated cleaning processes, reducing variability and cross-contamination risks.
• Seamless Integration & Upgrades – Available as a direct upgrade for existing NGI systems, extending instrument lifespan without disrupting workflows.

Expanding Your APSD Testing Capabilities

• Nebulizer & Biologic Testing – Overcomes the challenges of high-saline and protein-based formulations, ensuring impactor reliability.
• Increased Method Robustness – Reduces material degradation, providing consistent APSD data over time.
• Faster, More Reliable Cleaning – Enables automated or chemical-based cleaning, improving efficiency and reproducibility.

Upgrade Your APSD Measurements with NGI+!
Contact Us Today!